Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5319)
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
16,388
Price
$45.78
Total Value
$750.24K
Shares Held After
8,891,895
% of Holdings
0.2%
Protagonist Therapeutics, Inc (PTGX)
MOLINA ARTURO MD — Chief Medical Officer
Shares
15,000
Price
$104.79
Total Value
$1.57M
Shares Held After
84,115
% of Holdings
15.1%
Protagonist Therapeutics, Inc (PTGX)
SELICK HAROLD E — Director
Shares
24,000
Price
$105.00
Total Value
$2.52M
Shares Held After
60,845
% of Holdings
28.3%
Protagonist Therapeutics, Inc (PTGX)
Ali Asif — Chief Financial Officer
Shares
24,765
Price
$104.24
Total Value
$2.58M
Shares Held After
60,753
% of Holdings
29.0%
Centessa Pharmaceuticals plc (CNTA)
Anderson Karen M. — Chief People Officer
Shares
41,076
Price
$30.12
Total Value
$1.24M
Shares Held After
62,085
% of Holdings
39.8%
KalVista Pharmaceuticals, Inc. (KALV)
Venrock Healthcare Capital Partners III, L.P. — 10% Owner
Shares
3,183
Price
$19.12
Total Value
$60.86K
Shares Held After
5,089,354
% of Holdings
0.1%
KalVista Pharmaceuticals, Inc. (KALV)
Venrock Healthcare Capital Partners III, L.P. — 10% Owner
Shares
15,417
Price
$18.82
Total Value
$290.15K
Shares Held After
5,092,537
% of Holdings
0.3%
KalVista Pharmaceuticals, Inc. (KALV)
Venrock Healthcare Capital Partners III, L.P. — 10% Owner
Shares
21,386
Price
$17.76
Total Value
$379.82K
Shares Held After
5,107,954
% of Holdings
0.4%
iBio, Inc. (IBIO)
Banjak Marc — Chief Legal Officer
Shares
1,434
Price
$1.76
Total Value
$2.52K
Shares Held After
25,000
% of Holdings
5.7%
iBio, Inc. (IBIO)
Banjak Marc — Chief Legal Officer
Shares
12,500
Price
$1.64
Total Value
$20.53K
Shares Held After
23,566
% of Holdings
53.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
320
Price
$540.04
Total Value
$172.81K
Shares Held After
18,876
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
994
Price
$538.91
Total Value
$535.68K
Shares Held After
19,196
% of Holdings
4.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,149
Price
$537.90
Total Value
$618.05K
Shares Held After
20,190
% of Holdings
5.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,577
Price
$536.90
Total Value
$846.69K
Shares Held After
21,339
% of Holdings
6.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,003
Price
$535.94
Total Value
$1.07M
Shares Held After
22,916
% of Holdings
8.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,847
Price
$534.98
Total Value
$988.10K
Shares Held After
24,919
% of Holdings
6.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
609
Price
$533.91
Total Value
$325.15K
Shares Held After
26,766
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
510
Price
$532.93
Total Value
$271.79K
Shares Held After
27,375
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
991
Price
$532.02
Total Value
$527.24K
Shares Held After
27,885
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$539.98
Total Value
$151.19K
Shares Held After
40,513
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
740
Price
$538.90
Total Value
$398.79K
Shares Held After
40,793
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,100
Price
$537.97
Total Value
$591.77K
Shares Held After
41,533
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,540
Price
$536.96
Total Value
$826.91K
Shares Held After
42,633
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,029
Price
$536.00
Total Value
$1.09M
Shares Held After
44,173
% of Holdings
4.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,476
Price
$535.06
Total Value
$789.74K
Shares Held After
46,202
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
837
Price
$534.02
Total Value
$446.98K
Shares Held After
47,678
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
498
Price
$532.90
Total Value
$265.38K
Shares Held After
48,515
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
841
Price
$532.08
Total Value
$447.48K
Shares Held After
49,013
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
159
Price
$530.95
Total Value
$84.42K
Shares Held After
49,854
% of Holdings
0.3%
BECTON DICKINSON & CO (BDX)
Feld Michael — EVP, Chief Revenue Officer
Shares
75
Price
$156.83
Total Value
$11.76K
Shares Held After
21,233
% of Holdings
0.4%
Neuronetics, Inc. (STIM)
Chernett Jorey — 10% Owner
Shares
25,000
Price
$1.44
Total Value
$36.00K
Shares Held After
8,893,276
% of Holdings
0.3%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
280
Price
$57.17
Total Value
$16.01K
Shares Held After
52,200
% of Holdings
0.5%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
6,760
Price
$56.79
Total Value
$383.87K
Shares Held After
52,480
% of Holdings
11.4%
Centessa Pharmaceuticals plc (CNTA)
Weinhoff Gregory M — Chief Business Officer
Shares
23,998
Price
$30.00
Total Value
$719.94K
Shares Held After
65,925
% of Holdings
26.7%
ACADIA PHARMACEUTICALS INC (ACAD)
Kihara James — PRINCIPAL ACCOUNTING OFFICER
Shares
12
Price
$21.73
Total Value
$260.70
Shares Held After
26,885
% of Holdings
0.0%
ACADIA PHARMACEUTICALS INC (ACAD)
Kihara James — PRINCIPAL ACCOUNTING OFFICER
Shares
1,097
Price
$21.65
Total Value
$23.75K
Shares Held After
26,897
% of Holdings
3.9%
ACADIA PHARMACEUTICALS INC (ACAD)
Schneyer Mark C. — EVP, CHIEF FINANCIAL OFFICER
Shares
37
Price
$21.72
Total Value
$803.54
Shares Held After
60,269
% of Holdings
0.1%
ACADIA PHARMACEUTICALS INC (ACAD)
Schneyer Mark C. — EVP, CHIEF FINANCIAL OFFICER
Shares
3,171
Price
$21.65
Total Value
$68.65K
Shares Held After
60,306
% of Holdings
5.0%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$14.12
Total Value
$269.13K
Shares Held After
468,892
% of Holdings
3.9%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
5,319
Price
$5.40
Total Value
$28.72K
Shares Held After
532,091
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
Thompson Tommy G — Director
Shares
311
Price
$540.17
Total Value
$167.99K
Shares Held After
8,480
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
Thompson Tommy G — Director
Shares
1,414
Price
$539.25
Total Value
$762.49K
Shares Held After
8,791
% of Holdings
13.9%
UNITED THERAPEUTICS Corp (UTHR)
Thompson Tommy G — Director
Shares
275
Price
$537.62
Total Value
$147.85K
Shares Held After
10,205
% of Holdings
2.6%
IMPACT BIOMEDICAL INC. (IBO)
Macko Todd D — Chief Financial Officer
Shares
1,600
Price
$0.60
Total Value
$961.28
Shares Held After
198,122
% of Holdings
0.8%
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)
Chacon Quiros Juan Jose — Director
Shares
3,575
Price
$60.08
Total Value
$214.77K
Shares Held After
1,220,004
% of Holdings
0.3%
GLAUKOS Corp (GKOS)
Thurman Alex R. — SVP & CHIEF FINANCIAL OFFICER
Shares
2,511
Price
$106.46
Total Value
$267.32K
Shares Held After
41,967
% of Holdings
5.6%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
2,000
Price
$85.00
Total Value
$170.00K
Shares Held After
179,371
% of Holdings
1.1%
KalVista Pharmaceuticals, Inc. (KALV)
Venrock Healthcare Capital Partners III, L.P. — 10% Owner
Shares
160
Price
$17.53
Total Value
$2.80K
Shares Held After
5,129,340
% of Holdings
0.0%
KalVista Pharmaceuticals, Inc. (KALV)
Venrock Healthcare Capital Partners III, L.P. — 10% Owner
Shares
174,485
Price
$16.95
Total Value
$2.96M
Shares Held After
5,129,500
% of Holdings
3.3%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
40,000
Price
$35.10
Total Value
$1.40M
Shares Held After
25,000
% of Holdings
61.5%
Showing 151–200 of 5319 transactions (page 4 of 107)